According to the CDC, in 2008, over 200,000 women in the U.S. were diagnosed with breast cancer, and over 40,000 women in the U.S. died from it. What new weapons are drug companies adding to the arsenal against this disease? GEN has already given you the top 10 best-selling drugs of the 21st century; now, we present a list of drug candidates for which breast cancer is at least one proposed or approved indication, and for which one indication has reached Phase III or Registration phases.
Each entry includes the name of the drug candidate, the sponsor (and where applicable, collaboration partners), method of action, indication, and phase of trial. Some products are still in clinical trial phases for new indications or formulations after winning marketing approval for initial indications; these approvals, where applicable, are listed on the bottom of each entry.